Tag: Ariad Pharma

Finance

Biotech Active Runners: Hemispherx BioPharma (NYSEMKT:HEB), Rexahn Pharmaceuticals (NYSEMKT:RNN), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA)

Hemispherx Biopharma, Inc. (NYSE MKT:HEB) participated in the 11th Biennial International Research and Clinical Conference  held in San Francisco, California, USA, March 20-23, 2014. The title of the presentation is “Differential Exercise Responses to Rintatolimod [Ampligen(R)] Exhibited by Patients with Severe Chronic Fatigue Syndrome (CFS)”. This Phase III prospective, double-blind, randomized, placebo-controlled trial was conducted at twelve centers by leading researchers in fatigue and post-exertional … Continue reading Biotech Active Runners: Hemispherx BioPharma (NYSEMKT:HEB), Rexahn Pharmaceuticals (NYSEMKT:RNN), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA)

Jason Knox
Finance

Top Gainers: JA Solar Holdings (NASDAQ:JASO), magicJack VocalTec (NASDAQ:CALL), Ariad Pharmaceuticals (NASDAQ:ARIA), Millennial Media (NYSE:MM)

JA Solar Holdings Co (NASDAQ: JASO) is projected to report its Q4 earnings at $0.01 per share on revenue of $291.82 million. JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) stock performance was 8.25% in last session and finished the day at $11.42. Traded volume was 1,600.00million shares in the last session and the average volume of the stock remained 2.48million shares. The beta of the … Continue reading Top Gainers: JA Solar Holdings (NASDAQ:JASO), magicJack VocalTec (NASDAQ:CALL), Ariad Pharmaceuticals (NASDAQ:ARIA), Millennial Media (NYSE:MM)

Kevin Long
BioTech

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares declined 1.14% to $8.65. The company on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -2.87% in last session and finished the day at $8.13. Traded volume was 13.50million shares in the last session and the average volume … Continue reading Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Jason Knox